Trending Now
CymaBay Therapeutics Inc (NASDAQ: CBAY) Announces Promising Seladelpar Data In Treatment...
CymaBay Therapeutics Inc (NASDAQ: CBAY) has announced the presentation of promising seladelpar findings in primary biliary cholangitis (PBC) patients at The International Liver Congress...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Axovant Gene Therapies Ltd (NASDAQ:AXGT) Receives Rare Pediatric Disease Designation For...
Axovant Gene Therapies Ltd (NASDAQ:AXGT) recently announced that it was awarded rare disease designation for AXO-AAV-GM2, a gene therapy that it has been developing...
MAKE IT MODERN
LATEST REVIEWS
Top Penny Stocks In Focus (GROM,RSCZF,FFIE,GNS,VERB)
Grom Social Enterprises Inc (GROM) stock yesterday close the day at $2.22USD +0.5 (29.07%). However, GROM stock is gaining momentum in pre...
MAKE IT MODERN
PERFORMANCE TRAINING
Denison Mines Corp (NYSEAMERICAN: DNN) Gains 50% Ownership of JCU for $41 Million in...
Denison Mines Corp (NYSEAMERICAN: DNN) has gained 50% ownership of JCU Exploration Company. It is pretty excited to complete the acquisition, paying $20.5 million...
Alkermes plc. (NASDAQ: ALKS) Announce Commercial Availability of LYBALVI In Schizophrenia Treatment and Bipolar...
Alkermes plc. (NASDAQ: ALKS) has announced the availability of LYBALVI (olanzapine and samidorphan) in the US by prescription in schizophrenia treatment and for bipolar...
What Lies Ahead for the $150B Ad Industry (CMGR, ROKU, VIAC, PINS, SNAP, TTD)
There’s $150 billion in annual spending that has become homeless. It now wanders around the global economy, aimless, lost, searching for a...
Royalty Pharma plc (NASDAQ: RPRX) Releases Q2 2021 Financial Results and Raises Full-Year Outlook
Royalty Pharma plc (NASDAQ: RPRX) announced its Q2 2021 financial results and raised its full-year 2020 adjusted cash receipts guidance.
Royalty Pharma reports Q2 2021...
Aytu Bioscience Inc (NASDAQ:AYTU) Reports An Impressive Fiscal Q4 2020 Performance
Aytu Bioscience Inc (NASDAQ:AYTU) recently released its financial report for its fiscal Q4 2020 ended June 30, 2020, revealing impressive financial highlights.
The company’s net...
MAKE IT MODERN
